Results for preiskovancev translation from Slovenian to English

preiskovancev.
ise peripheral volume of distribution as a consequence of lower weight in japanese subjects.

Št. preiskovancev
no. of subjects

Število preiskovancev
number of subjects

Št. ogroženih preiskovancev
no. of subjects at risk

n = število preiskovancev
n = number of subjects

več kot polovica preiskovancev
six-month seizure freedom was achieved in 73.0% of levetiracetam-treated patients and 72.8% of carbamazepine-cr treated patients; the adjusted absolute difference between treatments was 0.2% (95% ci: -7.8 8.2).

populacija vseh zdravljenih preiskovancev
all treated subjects population

n = število randomiziranih preiskovancev
n = number of subjects randomised

n= število ocenjenih preiskovancev.
n= number of subjects evaluated.

odstotek preiskovancev s celjenjem sluznice
percentage of subjects with mucosal healing

2% preiskovancev s titri ≥1:28
2 % of subjects with titre ≥1:28

n = število preiskovancev nd = ni določeno
n = number of subjects nd = not determined

§ Število preiskovancev iz 2 kliničnih študij
§ number of subjects from 2 clinical studies

2delež preiskovancev, ki so bili pred cepljenjem seronegativni
sero- negative subjects prior to vaccina- tion n=7

manj kot polovica rizičnih preiskovancev je imelo dogodek.
fewer than half of at-risk subjects had an event.

odstotek preiskovancev v klinični remisiji in trajnejši remisiji
percentage of subjects in clinical remission and sustained remission

kognitivnega stanja preiskovancev ni bilo mogoče zanesljivo izmeriti.
the cognitive status of the subjects could not be determined reliably.

preiskovancev z boleznijo ledvic v končnem stadiju niso proučevali.
subjects with end-stage renal disease were not studied.

odstotek preiskovancev s kliničnim odzivom in trajnejšim kliničnim odzivom
percentage of subjects in clinical response and in sustained clinical response

za odmerka so omejenemu številu preiskovancev dali odmerke do 300 mg.
in a single-dose tolerability study, doses up to 300 mg were administered to a limited number of subjects with only minor symptoms reported.